A study conducted by the National Institutes of health reveals that there is great hope in the fight against multiple sclerosis. The study proposes the stem-cell transplants to be helpful in this battle. As stated by the study, the stem cell of one’s blood cells has a possibility of yielding long-term remission of MS symptoms. The results of this treatment known as immunosuppressive therapy and autologous hematopoietic cell transplant is breathtaking. The study results show that after the participants receiving a one-time treatment within a range of five years, 69 out of 100 encountered no progression of symptoms, new brain lesions or even relapse.
It is apparent that the one-time intervention is by far more implicative than the MS drugs commonly prescribed for treatment. However, there is the need for more research. The study is known as HALT-MS. It did an assessment on HDIT/HCT in 24 clinics with the participants having 26 to 52 years of age. All the participants had had the MS but continued to get worse. The treatment can, therefore, be an option to those people who fail to respond to other forms of treatments.
Dr. Shiva Gopal Vasishta made the discovery of the new technology. He is based in Voorhees and practices Neurology. He has more than 40 years of practice and is a graduate of the Government Medical College class of 1979. Dr. Shiva Gopal studied at Boston City Hospital, which is a significant brain injury center associated with Harvard University. He also has a specialty in psychiatry.
Medicare alongside some private insurance providers, for instance, Aetna are accepted in his office. As a neurologist, Dr. Shiva Gopal Vasishta treats all the disorders of the brain, spinal cord, peripheral nerves muscles and the other nervous systems that control organs such as the heart and the lungs. Shiva Gopal Vasishta may conduct an EEG test in case a patient has brain relates illness.